Colossal Biosciences Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Colossal Biosciences Inc. - overview
Established
2021
Location
Austin, TX, US
Primary Industry
Biotechnology
About
Founded in 2021 and based in Austin, US, Colossal Biosciences Inc. is a biotechnology firm focused on advanced genetic engineering aimed at de-extinction efforts of species like the Woolly Mammoth, contributing to biodiversity and ecosystem restoration. In September 2025. Colossal Biosciences Inc.
raised USD 120 million in Series C funding from US Innovative Technology Fund, Animal Capital and Individual investors which was part of a larger USD 320 million in series C funding. The company will use the funding to support its biotechnology research.
Current Investors
Capital Factory, Winklevoss Capital Management, First Light Capital
Primary Industry
Biotechnology
Sub Industries
Molecular Science, Genetics & Gene Therapy, Bioinformatics, Healthcare IT, Medical Devices & Equipment, Medical Software, Application Integration Software
Website
www.colossal.com/
Verticals
Artificial Intelligence, Cloud Computing, HealthTech, Manufacturing
Company Stage
Series C
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.